Oncology & Hematology Coding Alert

You Be the Coder:

36593 on Chemo Day: Yes or No?

Question: I know I can't report vascular access device flushing on the same date as chemotherapy, but what if the staff uses tPA to declot a vascular device? May I report that service separately? How should I code multiple injections? California SubscriberAnswer: You may report the vascular device declotting using tPA (tissue plasminogen activator) on the same date as chemotherapy administration. For the declotting service, you should report 36593 (Declotting by thrombolytic agent of implanted vascular access device or catheter). Note that use of a thrombolytic agent, such as the tPA you mention, is required for this code.Distinction: CPT® Assistant (December 2009) indicates that the 36593 service is not the same as routine flushing of a vascular access device using saline or heparin. As you note, routine flushing is included in the chemotherapy service and is not separately reportable.Multiple injections: If staff administers multiple thrombolytic injections for a single declotting [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All